Comprehensive Guide for Taking a Patient History in Gastrointestinal Clinical Practice
A thorough gastrointestinal (GI) clinical history begins by identifying the presenting symptoms in detail, including onset, duration, frequency, pattern, and severity, as these can help differentiate between organic and functional disorders NICE CKS. For example, in dyspepsia, ask about alarm symptoms and symptom impact on quality of life, while for irritable bowel syndrome (IBS), ascertain abdominal pain characteristics and stool form using tools such as the Bristol Stool Form Scale to improve description NICE CKS,NICE CKS,NICE CG61.
It is important to explore specific symptom attributes depending on clinical context: for dyspepsia, inquire about triggers like coffee, fatty or spicy foods, eating patterns, and medication history including over-the-counter remedies and drugs that can exacerbate symptoms such as NSAIDs or corticosteroids NICE CKS,Shareef et al. 2025. For suspected gastroenteritis, gather details on diarrhea characteristics (presence of blood, mucus), nausea, vomiting, fever, exposure risks (food, travel, contacts), and risk factors for dehydration or complications NICE CKS. In diverticular disease, probe pain features, bowel changes, and associated symptoms like bleeding or fever NICE CKS.
Family history of GI malignancies or relevant conditions should be sought as it impacts risk stratification and decisions for investigation NICE CKS,NICE CKS. Lifestyle factors including smoking status, alcohol consumption, diet, exercise, and psychological stressors such as anxiety and depression must also be assessed as they influence symptom etiology and management NICE CKS,NICE CKS,NICE CG61.
Medication review is crucial for identifying contributors to GI symptoms as well as assessing adverse risks; this includes prescription, over-the-counter, and recent antibiotic use which may affect microbiota and GI function NICE CKS,NICE CKS,Shareef et al. 2025. Assessment of non-gastrointestinal symptoms (e.g., lethargy, backache, bladder symptoms) can provide context for functional disorders such as IBS NICE CG61.
Physical and psychological comorbidities, prior surgeries, and immunosuppression status should be recorded NICE CKS,NICE CKS. For pediatric populations, history should include stool patterns, growth, and signs of constipation or underlying disease, along with developmental milestones and possible precipitating factors NICE CG99.
In line with the evidence, certain alarm features (such as weight loss, anemia, abdominal masses, bleeding) should prompt urgent investigation or referral NICE CKS,NICE CKS,NICE CKS,NICE CG61. Consider also patient factors like age and epidemiological risks (e.g., exposure to Helicobacter pylori, based on local prevalence and eradication history) that influence investigation thresholds and management strategy [1, (Lu and Gao YZ., 2026)].
Because some GI symptoms persist post H. pylori eradication and organic causes are frequently absent on endoscopy, history-taking should allow for recognizing functional dyspepsia and the need for tailored, symptom-based management beyond eradication therapy [ (Lu and Gao YZ., 2026)].
Clinical history taking should sensitively explore symptom impact on daily functioning and psychosocial factors, considering communication needs related to culture, language, and cognitive status, to facilitate shared decision-making and patient engagement in management plans NICE CG61.
Key References
- CKS - Dyspepsia - unidentified cause
- CKS - Irritable bowel syndrome
- CKS - Gastroenteritis
- CKS - Diverticular disease
- CG61 - Irritable bowel syndrome in adults: diagnosis and management
- CG99 - Constipation in children and young people: diagnosis and management
- (Moayyedi et al., 2017): ACG and CAG Clinical Guideline: Management of Dyspepsia.
- (Moshiree et al., 2023): AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review.
- (Unknown, 2026): Poster Session I - A117 IMPACT OF PATIENT AND PHYSICIAN GENDER ON PHYSICIAN ASSESSMENT OF IBD REFERRALS
- (Shareef et al., 2025): Balancing Pain Relief and Safety: Gastrointestinal and Cardiovascular Risk Assessment in Nonsteroidal Anti-Inflammatory Drug Users and the Role of Gastroprotective Co-Therapy.
- (Lu and Gao YZ., 2026): Dyspepsia following <i>Helicobacter pylori</i> eradication: Shifts in etiology and clinical challenges.